These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8382482)

  • 1. Thrombin receptor agonist peptide induction of mitogenesis in CCL39 cells.
    Reilly CF; Connolly TM; Feng DM; Nutt RF; Mayer EJ
    Biochem Biophys Res Commun; 1993 Feb; 190(3):1001-8. PubMed ID: 8382482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis.
    Vouret-Craviari V; Van Obberghen-Schilling E; Rasmussen UB; Pavirani A; Lecocq JP; Pouysségur J
    Mol Biol Cell; 1992 Jan; 3(1):95-102. PubMed ID: 1312881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
    Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
    Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
    Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ
    Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist.
    Vouret-Craviari V; Van Obberghen-Schilling E; Scimeca JC; Van Obberghen E; Pouysségur J
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):209-14. PubMed ID: 8380983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of biotinylated thrombin receptor peptide to cloned human thrombin receptor overexpressed in baby hamster kidney cells.
    Takada M; Ito O; Kogushi M; Kobayashi H; Yamada T; Tanaka H; Yoshitake S; Saito I
    J Recept Signal Transduct Res; 1995; 15(1-4):103-15. PubMed ID: 8903935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides.
    Van Obberghen-Schilling E; Rasmussen UB; Vouret-Craviari V; Lentes KU; Pavirani A; Pouysségur J
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):667-71. PubMed ID: 7686363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.
    McNamara CA; Sarembock IJ; Gimple LW; Fenton JW; Coughlin SR; Owens GK
    J Clin Invest; 1993 Jan; 91(1):94-8. PubMed ID: 8380817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.
    Gerszten RE; Chen J; Ishii M; Ishii K; Wang L; Nanevicz T; Turck CW; Vu TK; Coughlin SR
    Nature; 1994 Apr; 368(6472):648-51. PubMed ID: 8145852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of growth factor "relaxation" in Chinese hamster lung fibroblasts required for tumoral expression.
    Van Obberghen-Schilling E; Pérez-Rodríguez R; Franchi A; Chambard JC; Pouysségur J
    J Cell Physiol; 1983 May; 115(2):123-30. PubMed ID: 6188755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a peptide antagonist to the thrombin receptor using phage display.
    Doorbar J; Winter G
    J Mol Biol; 1994 Dec; 244(4):361-9. PubMed ID: 7990127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP-dependence of platelet activation induced by a thrombin receptor agonist.
    Savi P; Dol F; Herbert JM
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):115-9. PubMed ID: 8392699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide.
    Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA
    Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells.
    DiCuccio MN; Shami P; Hoffman M
    Exp Hematol; 1996 Jul; 24(8):914-8. PubMed ID: 8690050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual thrombin receptor system for platelet activation.
    Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
    Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent activation of endogenous p21-activated protein kinase-3 (PAK3) and JNK by thrombin in CCL39 fibroblasts.
    Malcolm KC; Chambard JC; Grall D; Pouysségur J; van Obberghen-Schilling E
    J Cell Physiol; 2000 Nov; 185(2):235-43. PubMed ID: 11025445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cells exhibit differential chemokinetic and mitogenic responsiveness to alpha-thrombin.
    Wang HS; Li F; Runge MS; Chaikof EL
    J Surg Res; 1997 Mar; 68(2):139-44. PubMed ID: 9184672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.